Abstract
The aim of this work was to study the expression of human leukocyte antigen G (HLA-G) and interleukin 10 (IL-10) in conjunction with expression of HLA-G killer-cell inhibitory receptor ligand immunoglobulin-like transcript 2 (ILT2) in CD3+, CD19+, CD56+ lymphomas, and ILT4 in CD14+ cells from patients with systemic lupus erythematosus (SLE). Thirty-one SLE patients and 36 healthy controls were studied. ILTs expression was analyzed by flow cytometry in peripheral blood mononuclear cells (PBMCs). The plasma sHLA-G and IL10 were evaluated by enzyme-linked immunosorbent assay (ELISA). We found a significant increased expression of ILT2 by lymphocytes in SLE patients. When the expression of this receptor was assessed in cell subsets, significantly higher ILT2 MRFI levels were detected in CD3+ cells, CD19+ cells, CD56+ cells (P < 0.05), but no change with ILT4 MRFI in CD14+ cells, neither did the percentages of ILT2/4+ lymphocytes change in SLE patients compared with healthy controls (P > 0.05). The upregulation of ILT2 expression was related to IL10 and anti-ds-DNA antibodies (P < 0.05), but not sHLA-G and steroid therapy (P > 0.05). IL-10 and sHLA-G were increased, but did not change remarkably (P > 0.05); however, they were quite related (P < 0.05). ILT2 might be one of the factors accounting for the evasion of immunosurveillance, thus participate in the pathogenesis of SLE, and the upregulation of ILT2 may be associated with its disease activity.
Similar content being viewed by others
References
Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus[J]. J Clin Pathol 56(7):481–490
Renaudineau Y, Pers JO, Bendaoud B et al (2004) Dysfunctional B cells in systemic lupus erythematosus[J]. Autoimmun Rev 3(7–8):516–523
Brown D, Trowsdale J, Allen R (2004) The LILR family: modulators of innate and adaptive immune pathways in health and disease[J]. Tissue Antigens 64(3):215–225
Sayós J, Martínez-Barriocanal A, Kitzig F et al (2004) Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j[J]. Biochem Biophys Res Commun 324(2):640–647
Colonna M, Navarro F, Bellon T et al (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells[J]. J Exp Med 186(11):1809–1818
Saverino D, Merlo A, Bruno S, et al (2002) Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen- stimulated human T cells[J]. J Immunol 168(1):207–215
Navarro F, Llano M, Bellon T, et al (1999) The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells[J]. Eur J Immunol 29(1):277–283
Colonna M, Nakajima H, Navarro F et al (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells[J]. J Leukoc Biol 66(3):375–381
Gregori S, Tomasoni D, Pacciani V, et al (2010) Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood[J] 116(6):935–944
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum 25:1271–1277
Le Gal FA, Riteau B, Sedlik C et al (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes[J]. Int Immunol 11(8):1351–1356
Pazmany L, Mandelboim O, Valeś-Gómez M et al (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells [J]. Science 274(5288):792–795
Contini P,Ghio M,Poggi A et al (2003) SolubleHLA-A;-B;-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation [J]. Eur J Immunol 33:125–134
Fournel S, Aguerre-Girr M, Huc X et al (2000) Cutting edge, soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J]. J Immunol 164(12):6100–6104
Bainbridge DR, Ellis SA, Sargent IL (2000) HLA-G suppresses proliferation of CD4(+) T-lymphocytes [J]. J Reprod Immunol 48(1):17–26
Lila N, Rouas-Freiss N, Dausset J et al (2001) Soluble HLA-G protein secreted by allospecific CD4+ T cells suppresses the alloproliferative response, a CD4+ T cell regulatory mechanism [J]. Proc Natl Acad Sci USA 98(21):12150–12155
Gregori S, Magnani CF, Roncarolo MG (2009) Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells [J]. Hum Immunol 70(12):966–969
Liang S, Horuzsko A (2003) Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 64(11):1025–1032
Monsiváis-Urenda A, Niño-Moreno P, Abud Mendoza C et al (2007) Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus(SLE). J Autoimmun 29 (2–3):97–105
Kalmbach Y, Boldt AB, Fendel R et al (2006) Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. Eur Cytokine Netw 17(3):175–180
Kuroki K, Tsuchiya N, Shiroishi M et al (2005) Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis[J]. Hum Mol Genet 14(16):2469–2480
LeMaoult J, Zafaranloo K, Le Danff C et al (2005) HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19(6):662–664
Urosevic M, Dummer R (2003) HLA-G and IL-10 expression in human cancer: different stories with the same message. Semin Cancer Biol 13(5):337–342
Boulland ML, Meignin V, Leroy-Viard K et al (1998) Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Am J Pathol 153:1229–1237
Urosevic M, Willers J, Mueller B et al (2002) HLA-G protein up-regulation in primary cutaneous lymphomas is associated with IL-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99:609–617
Beinhauer BG, McBride JM, Graf P et al (2004) Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol 34:74–80
Rosado S, Perez-Chacon G, Mellor-Pita S et al (2008) Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 69(1):9–15
Rizzo R, Hviid TV, Govoni M et al (2008) HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71(6):520–529
Rudstein-Svetlicky N, Loewenthal R, Horejsi V et al (2007) HLA-G levels in serum and plasma. Tissue Antigens 69(1):140–142
Rudstein-Svetlicky N, Loewenthal R, Horejsi V et al (2006) HLA-G levels in serum and plasma. Tissue Antigens 67(2):111–116
Acknowledgments
Supported by grant 2010C33001 from Science Technology of Zhejiang Province and grant 2011C33044 from public technology social development project by department of Science and Technology of Zhejiang Province.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Chen, J., Shen, B., Jiang, Y. et al. Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med 13, 135–142 (2013). https://doi.org/10.1007/s10238-012-0185-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-012-0185-6